These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 24604080)

  • 1. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.
    Héraud C; Goufak D; Ando K; Leroy K; Suain V; Yilmaz Z; De Decker R; Authelet M; Laporte V; Octave JN; Brion JP
    Neurobiol Dis; 2014 Feb; 62():100-12. PubMed ID: 24076100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
    Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
    Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
    Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
    J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model.
    Yoshiyama Y; Uryu K; Higuchi M; Longhi L; Hoover R; Fujimoto S; McIntosh T; Lee VM; Trojanowski JQ
    J Neurotrauma; 2005 Oct; 22(10):1134-41. PubMed ID: 16238489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
    Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
    Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.